Martingale Asset Management L P Sana Biotechnology, Inc. Transaction History

Martingale Asset Management L P

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$5.23 - $10.44 $35,867 - $71,597	-6,858 Reduced 13.94%	42,338 $231,000
Q1 2024 May 14, 2024	SELL	$4.2 - $11.27 $44,129 - $118,413	-10,507 Reduced 17.6%	49,196 $491,000
Q3 2023 Nov 14, 2023	SELL	$3.77 - $6.23 $86 - $143	-23 Reduced 0.04%	59,703 $231,000
Q2 2023 Aug 11, 2023	BUY	$3.22 - $7.53 $9,051 - $21,166	2,811 Added 4.94%	59,726 $355,000
Q4 2022 Feb 13, 2023	BUY	$3.19 - $6.46 $2,233 - $4,522	700 Added 1.25%	56,915 $224,000
Q2 2022 Aug 11, 2022	BUY	$4.12 - $9.35 $72,219 - $163,896	17,529 Added 45.31%	56,215 $361,000
Q1 2022 May 12, 2022	BUY	$5.24 - $15.58 $202,714 - $602,727	38,686 New	38,686 $319,000

174

121M

1.87M

1.48M

Ticker SANA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 190,232,000
Market Cap $310M
Description
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

Stay updated on Martingale Asset Management L P with notifications on news.